이식형 심장 모니터(ICM) 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2025-2034년)

The Global Implantable Cardiac Monitor Market was valued at USD 910.4 million in 2024 and is estimated to grow at a CAGR of 6.3% to reach USD 1.7 billion by 2034.

The rising prevalence of cardiovascular diseases, an aging population, and the increasing need for continuous remote cardiac monitoring are driving market expansion. Technological advancements in remote monitoring solutions are also contributing to growth by enhancing patient outcomes and enabling timely intervention. Implantable cardiac monitors provide hospitals, specialized cardiac centers, ambulatory surgical facilities, and health technology companies with advanced solutions to detect arrhythmias early and streamline clinical workflows. Long-term implantable loop recorders, wireless transmission systems, and remote monitoring technologies allow continuous rhythm tracking, early diagnosis, and personalized patient management. With the global population aging, chronic cardiovascular conditions are becoming more common, further increasing demand for long-term monitoring. Greater awareness among healthcare providers and patients regarding early arrhythmia detection and continuous monitoring is boosting market adoption. Miniaturized devices and wireless connectivity have also improved patient compliance and clinical efficiency.

The atrial fibrillation segment held a 41.8% share in 2024. This leadership is driven by the rising prevalence of AF, heightened stroke risk, and demand for early diagnosis, which makes continuous implantable monitoring essential. Atrial fibrillation remains the most common cardiac arrhythmia, particularly among older adults and patients with underlying cardiovascular disorders. Early detection through long-term monitoring helps prevent serious complications, including stroke and heart failure.

The hospitals segment held a 52.7% share and is expected to reach USD 903.7 million during 2025-2034. Hospitals dominate because of their advanced infrastructure, specialized cardiology departments, and skilled personnel capable of performing implantable procedures. The increasing incidence of arrhythmias and atrial fibrillation among inpatients fuels demand for continuous monitoring. Integration with electronic health records and remote monitoring platforms further enhances hospital efficiency and patient data management.

North America Implantable Cardiac Monitor Market held a 35.5% share in 2024. The region benefits from a high prevalence of cardiovascular conditions among its elderly population, a well-established healthcare infrastructure, and an extensive network of hospitals and specialty cardiac centers equipped for implantable procedures. Adoption is further supported by technological innovations such as miniaturized loop recorders, wireless monitoring systems, and AI-driven predictive analytics, which enhance patient outcomes and improve operational efficiency.

Key players in the Implantable Cardiac Monitor Market include Medtronic, Vectorious Medical Technologies, Abbott, BIOTRONIK, Boston Scientific, and AngelMed / Avertix. Companies in the Implantable Cardiac Monitor Market are strengthening their presence by investing in R&D to develop miniaturized, energy-efficient devices with wireless and remote monitoring capabilities. Many are forming strategic collaborations with hospitals, cardiology centers, and technology providers to integrate their ICM systems into clinical workflows. Companies are also expanding their geographical footprint and distribution networks to access emerging markets. Enhancing software platforms for predictive analytics, AI-driven diagnostics, and real-time patient monitoring is another key strategy.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Indication trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of cardiac arrhythmias and atrial fibrillation
    • 3.2.1.2 Advancements in remote monitoring and connectivity technologies
    • 3.2.1.3 Growing geriatric population and associated cardiac risk
    • 3.2.1.4 Favorable reimbursement policies and early diagnosis programs
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of devices and implantation procedures
    • 3.2.2.2 Limited awareness among patients and general practitioners
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration with artificial intelligence and predictive analytics
    • 3.2.3.2 Development of smart, miniaturized, and long-life devices
• 3.3 Growth potential analysis
• 3.4 Pricing analysis, 2024
• 3.5 Number of implantable cardiac monitors sold (Units), 2021 - 2034
  • 3.5.1 Global
  • 3.5.2 North America
  • 3.5.3 Europe
  • 3.5.4 Asia Pacific
  • 3.5.5 Latin America
  • 3.5.6 MEA
• 3.6 Regulatory landscape
  • 3.6.1 North America
  • 3.6.2 Europe
  • 3.6.3 Asia Pacific
  • 3.6.4 LAMEA
• 3.7 Technological advancements
  • 3.7.1 Current technological trends
    • 3.7.1.1 Miniaturized implantable loop recorders for long-term cardiac monitoring
    • 3.7.1.2 Remote monitoring platforms enabling real-time heart rhythm data transmission
    • 3.7.1.3 Patient-friendly, minimally invasive devices improving comfort and procedural efficiency
  • 3.7.2 Emerging technologies
    • 3.7.2.1 AI-powered arrhythmia detection and predictive analytics for early diagnosis
    • 3.7.2.2 Wireless connected implantable cardiac monitors integrating smartphone and cloud platforms
    • 3.7.2.3 Smart devices with adaptive alert systems and automated clinician notifications
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Future market trends
  • 3.11.1 Convergence of AI, digital health, and connected cardiac devices
  • 3.11.2 Expansion of home-based and outpatient cardiac monitoring solutions
  • 3.11.3 Growth in emerging markets with improving healthcare infrastructure

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New service type launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Atrial fibrillation (AF)
• 5.3 Arrhythmia
• 5.4 Bradycardia
• 5.5 Tachycardia
• 5.6 Other indications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Specialized cardiac centers
• 6.4 Ambulatory surgical centers
• 6.5 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Abbott
• 8.2 AngelMed / Avertix
• 8.3 BIOTRONIK
• 8.4 Boston Scientific
• 8.5 Medtronic
• 8.6 Vectorious Medical Technologies